Pharmacokinetic and pharmacodynamic interactions in anaesthesia. A review of current knowledge and how it can be used to optimize anaesthetic drug administration.

This review describes the basics of pharmacokinetic and pharmacodynamic drug interactions and methodological points of particular interest when designing drug interaction studies. It also provides an overview of the available literature concerning interactions, with emphasis on graphic representation of interactions using isoboles and response surface models. It gives examples on how to transform this knowledge into clinically and educationally applicable (bedside) tools.

[1]  L. Benet,et al.  Changes in plasma protein binding have little clinical relevance , 2002, Clinical pharmacology and therapeutics.

[2]  T. Schnider,et al.  Study of the time course of the clinical effect of propofol compared with the time course of the predicted effect-site concentration: Performance of three pharmacokinetic-dynamic models. , 2010, British journal of anaesthesia.

[3]  O. U. Petring,et al.  General Anaesthesia with Halothane and Drug Absorption: The Effect of General Anaesthesia with Halothane and Diazepam on Postoperative Gastric Emptying in Man , 1984, Acta anaesthesiologica Scandinavica.

[4]  H. Robb,et al.  The influence of esmolol on the dose of propofol required for induction of anaesthesia * , 2004, Anaesthesia.

[5]  Alan F Merry,et al.  Refining Target-Controlled Infusion: An Assessment of Pharmacodynamic Target-Controlled Infusion of Propofol and Remifentanil Using a Response Surface Model of Their Combined Effects on Bispectral Index , 2016, Anesthesia and analgesia.

[6]  J. Sear,et al.  Real time monitoring of propofol blood concentration in ponies anaesthetized with propofol and ketamine. , 2013, Journal of veterinary pharmacology and therapeutics.

[7]  E. Eger,et al.  Minimum alveolar anesthetic concentration: a standard of anesthetic potency. , 1965, Anesthesiology.

[8]  R. Tufano,et al.  Navigator® and SmartPilot® View are helpful in guiding anesthesia and reducing anesthetic drug dosing. , 2015, Minerva anestesiologica.

[9]  E. Perucca,et al.  Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs , 2003, The Lancet Neurology.

[10]  A Hoeft,et al.  Propofol and remifentanil pharmacodynamic interaction during orthopedic surgical procedures as measured by effects on bispectral index. , 2001, Journal of clinical anesthesia.

[11]  David F. Kisor,et al.  Clinical Pharmacokinetics of Cisatracurium Besilate , 1999, Clinical pharmacokinetics.

[12]  J. Ropars,et al.  Propofol-sufentanil anesthesia for thyroid surgery: optimal concentrations for hemodynamic and electroencephalogram stability, and recovery features. , 2002, Anesthesia and analgesia.

[13]  C. Deng,et al.  Remifentanil-sevoflurane interaction models of circulatory response to laryngoscopy and circulatory depression. , 2013, British journal of anaesthesia.

[14]  P. Laitenberger,et al.  Evaluation of a new analyser for rapid measurement of blood propofol concentration during cardiac surgery , 2012, Anaesthesia.

[15]  N. Morton,et al.  Pharmacokinetic model driven infusion of propofol in children. , 1991, British journal of anaesthesia.

[16]  J. Dembo.  Propofol and midazolam act synergistically in combination , 1992 .

[17]  G N Kenny,et al.  Development of the technology for ‘Diprifusor’ TCI systems , 1998, Anaesthesia.

[18]  M. Struys,et al.  Propofol Breath Monitoring as a Potential Tool to Improve the Prediction of Intraoperative Plasma Concentrations , 2015, Clinical Pharmacokinetics.

[19]  Y. Du,et al.  On-line measurement of propofol using membrane inlet ion mobility spectrometer. , 2012, Talanta.

[20]  M. Struys,et al.  Optimizing intravenous drug administration by applying pharmacokinetic/pharmacodynamic concepts. , 2011, British journal of anaesthesia.

[21]  M. Struys,et al.  Administration and monitoring of intravenous anesthetics , 2010, Current opinion in anaesthesiology.

[22]  Manfred Morari,et al.  The Well-being Model: A New Drug Interaction Model for Positive and Negative Effects , 2006, Anesthesiology.

[23]  P. Despland,et al.  Midazolam premedication reduces propofol dose requirements for multiple anesthetic endpoints , 2001, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[24]  S. Shafer,et al.  Variability of Target-controlled Infusion Is Less Than the Variability after Bolus Injection , 2005, Anesthesiology.

[25]  J. Proost,et al.  Urinary, biliary and faecal excretion of rocuronium in humans. , 2000, British journal of anaesthesia.

[26]  E. Bradley,et al.  Triple Anesthetic Combination: Propofol‐Midazolam‐Alfentanil , 1994, Anesthesia and analgesia.

[27]  S. Shafer.  All models are wrong. , 2012, Anesthesiology.

[28]  A. McEwan,et al.  Isoflurane Minimum Alveolar Concentration Reduction by Fentanyl , 1993, Anesthesiology.

[29]  Erik Olofsen,et al.  Response Surface Modeling of Remifentanil–Propofol Interaction on Cardiorespiratory Control and Bispectral Index , 2003, Anesthesiology.

[30]  T. Kazama,et al.  The Pharmacodynamic Interaction between Propofol and Fentanyl with Respect to the Suppression of Somatic or Hemodynamic Responses to Skin Incision, Peritoneum Incision, and Abdominal Wall Retraction , 1998, Anesthesiology.

[31]  W R Greco,et al.  Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. , 1990, Cancer research.

[32]  Mingcang Wang,et al.  Prediction of effect-site concentration of sufentanil by dose-response target controlled infusion of sufentanil and propofol for analgesic and sedation maintenance in burn dressing changes. , 2014, Burns : journal of the International Society for Burn Injuries.

[33]  A. Dahan,et al.  Anesthetic Potency and Influence of Morphine and Sevoflurane on Respiration in &mgr;-Opioid Receptor Knockout Mice , 2001, Anesthesiology.

[34]  D. Eleveld,et al.  Performance of Propofol Target-Controlled Infusion Models in the Obese: Pharmacokinetic and Pharmacodynamic Analysis , 2014, Anesthesia and analgesia.

[35]  Y. Adachi,et al.  The Interaction Between Propofol and Clonidine for Loss of Consciousness , 2002, Anesthesia and analgesia.

[36]  P. Steen,et al.  Bispectral index, serum drug concentrations and emergence associated with individually adjusted target-controlled infusions of remifentanil and propofol for laparoscopic surgery. , 2003, British journal of anaesthesia.

[37]  R N Upton,et al.  A physiological model of induction of anaesthesia with propofol in sheep. 2. Model analysis and implications for dose requirements. , 1997, British journal of anaesthesia.

[38]  A. Zbinden,et al.  Is the end-tidal partial pressure of isoflurane a good predictor of its arterial partial pressure? , 1991, British journal of anaesthesia.

[39]  S. Schraag,et al.  Interaction modeling of propofol and sufentanil on loss of consciousness. , 1999, Journal of clinical anesthesia.

[40]  A. McKay,et al.  Synergistic interaction between midazolam and propofol. , 1992, British journal of anaesthesia.

[41]  S. Kreuer,et al.  Two different approaches for pharmacokinetic modeling of exhaled drug concentrations , 2014, Scientific Reports.

[42]  T. Bouillon,et al.  Probability to tolerate laryngoscopy and noxious stimulation response index as general indicators of the anaesthetic potency of sevoflurane, propofol, and remifentanil. , 2016, British journal of anaesthesia.

[43]  Thomas W. Schnider,et al.  Pharmacokinetics and Pharmacodynamics of Remifentanil , 1997 .

[44]  Cris D. LaPierre,et al.  A Simulation Study of Common Propofol and Propofol-Opioid Dosing Regimens for Upper Endoscopy: Implications on the Time Course of Recovery , 2012, Anesthesiology.

[45]  E. Olofsen,et al.  Pharmacodynamic Interaction between Propofol and Alfentanil When Given for Induction of Anesthesia , 1996, Anesthesiology.

[46]  Steven L Shafer,et al.  Is Synergy the Rule? A Review of Anesthetic Interactions Producing Hypnosis and Immobility , 2008, Anesthesia and analgesia.

[47]  M. Varner,et al.  Principles of Pharmacokinetics in the Pregnant Woman and Fetus. , 2019, Clinics in perinatology.

[48]  Cris D. LaPierre,et al.  An Exploration of Remifentanil-Propofol Combinations That Lead to a Loss of Response to Esophageal Instrumentation, a Loss of Responsiveness, and/or Onset of Intolerable Ventilatory Depression , 2011, Anesthesia and analgesia.

[49]  S. Shafer,et al.  The Influence of Method of Administration and Covariates on the Pharmacokinetics of Propofol in Adult Volunteers , 1998, Anesthesiology.

[50]  Edward H. Kerns,et al.  The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery , 2010, Nature Reviews Drug Discovery.

[51]  P. Sebel,et al.  Interaction of Propofol and Sevoflurane on Loss of Consciousness and Movement to Skin Incision during General Anesthesia , 2006, Anesthesiology.

[52]  A. Yli-Hankala,et al.  Time‐frequency balanced spectral entropy as a measure of anesthetic drug effect in central nervous system during sevoflurane, propofol, and thiopental anesthesia , 2004, Acta anaesthesiologica Scandinavica.

[53]  M Jospin,et al.  Validation of the index of consciousness during sevoflurane and remifentanil anaesthesia: a comparison with the bispectral index and the cerebral state index. , 2008, British journal of anaesthesia.

[54]  M. Struys,et al.  Accuracy of the Composite Variability Index as a Measure of the Balance Between Nociception and Antinociception During Anesthesia , 2014, Anesthesia and analgesia.

[55]  Peter M. Schumacher,et al.  Response Surface Modeling of the Interaction between Propofol and Sevoflurane , 2009, Anesthesiology.

[56]  P. Sebel,et al.  Fentanyl or Alfentanil Decreases the Minimum Alveolar Anesthetic Concentration of Isoflurane in Surgical Patients , 1994, Anesthesia and analgesia.

[57]  K. Ikeda,et al.  Sevoflurane requirements for tracheal intubation with and without fentanyl. , 1999, British journal of anaesthesia.

[58]  M. Ratain,et al.  Principles of Pharmacokinetics , 2003 .

[59]  Hugo Vereecke,et al.  Spectral Entropy as an Electroencephalographic Measure of Anesthetic Drug Effect: A Comparison with Bispectral Index and Processed Midlatency Auditory Evoked Response , 2004, Anesthesiology.

[60]  S. Shafer,et al.  Efficient Trial Design for Eliciting a Pharmacokinetic– Pharmacodynamic Model–based Response Surface Describing the Interaction between Two Intravenous Anesthetic Drugs , 2002, Anesthesiology.

[61]  M. Struys,et al.  Population pharmacokinetics and pharmacodynamics in anesthesia, intensive care and pain medicine , 2010, Current opinion in anaesthesiology.

[62]  J. Plummer,et al.  Hypnotic and anaesthetic interactions between midazolam, propofol and alfentanil. , 1992, British journal of anaesthesia.

[63]  Talmage D Egan,et al.  Response Surface Model Predictions of Emergence and Response to Pain in the Recovery Room: An Evaluation of Patients Emerging from an Isoflurane and Fentanyl Anesthetic , 2009, Anesthesia and analgesia.

[64]  A F Merry,et al.  Simulators for use in anaesthesia , 2007, Anaesthesia.

[65]  Olivier Thas,et al.  New Composite Index Based on Midlatency Auditory Evoked Potential and Electroencephalographic Parameters to Optimize Correlation with Propofol Effect Site Concentration: Comparison with Bispectral Index and Solitary Used Fast Extracting Auditory Evoked Potential Index , 2005, Anesthesiology.

[66]  M. Karol,et al.  Effect of dexmedetomidine on propofol requirements in healthy subjects. , 2001, Journal of pharmaceutical sciences.

[67]  T. Short.  Using response surfaces to expand the utility of MAC. , 2010, Anesthesia and analgesia.

[68]  J. Bruhn,et al.  Pharmacodynamic Interaction between Propofol and Remifentanil Regarding Hypnosis, Tolerance of Laryngoscopy, Bispectral Index, and Electroencephalographic Approximate Entropy , 2004, Anesthesiology.

[69]  J. Glen,et al.  The development of ‘Diprifusor’: a TCI system for propofol , 1998, Anaesthesia.

[70]  Matthew Fidler,et al.  Flexible Interaction Model for Complex Interactions of Multiple Anesthetics , 2006, Anesthesiology.

[71]  N. T. Smith,et al.  A Multicenter Study of Bispectral Electroencephalogram Analysis for Monitoring Anesthetic Effect , 1997, Anesthesia and analgesia.

[72]  M. Struys,et al.  Interaction between Nitrous Oxide, Sevoflurane, and Opioids: A Response Surface Approach , 2013, Anesthesiology.

[73]  S L Shafer,et al.  Pharmacokinetics and Pharmacodynamics of Remifentanil: II. Model Application , 1997, Anesthesiology.

[74]  Y. Adachi,et al.  The Determinants of Propofol Induction of Anesthesia Dose , 2001, Anesthesia and analgesia.

[75]  M. Struys,et al.  Simulated Drug Administration: An Emerging Tool for Teaching Clinical Pharmacology During Anesthesiology Training , 2008, Clinical pharmacology and therapeutics.

[76]  N. Edwards,et al.  Randomized placebo-controlled trial to assess the effect of remifentanil and propofol on bispectral index and sedation. , 2000, British journal of anaesthesia.

[77]  Peter S. Sebel,et al.  Eeg bispectrum predicts movement during thiopental/isoflurane anesthesia , 1995, Journal of Clinical Monitoring.

[78]  David W. Bates,et al.  Review Paper: What Evidence Supports the Use of Computerized Alerts and Prompts to Improve Clinicians' Prescribing Behavior? , 2009, J. Am. Medical Informatics Assoc..

[79]  P. Sebel,et al.  Reduction of the MAC of desflurane with fentanyl. , 1992, Anesthesiology.

[80]  J Schüttler,et al.  Population Pharmacokinetics of Propofol: A Multicenter Study , 2000, Anesthesiology.

[81]  Michel Struys,et al.  Comparisons of Electroencephalographically Derived Measures of Hypnosis and Antinociception in Response to Standardized Stimuli During Target-Controlled Propofol-Remifentanil Anesthesia , 2016, Anesthesia and analgesia.

[82]  M. Struys,et al.  Development of an Optimized Pharmacokinetic Model of Dexmedetomidine Using Target-controlled Infusion in Healthy Volunteers , 2015, Anesthesiology.

[83]  Sandeep C. Manyam,et al.  An Evaluation of Remifentanil Propofol Response Surfaces for Loss of Responsiveness, Loss of Response to Surrogates of Painful Stimuli and Laryngoscopy in Patients Undergoing Elective Surgery , 2008, Anesthesia and analgesia.

[84]  A. McEwan,et al.  The Interaction of Fentanyl on the Cp50 of Propofol for Loss of Consciousness and Skin Incision , 1994, Anesthesiology.

[85]  B. Golianu,et al.  Determination of the pharmacodynamic interaction of propofol and dexmedetomidine during esophagogastroduodenoscopy in children , 2009, Paediatric anaesthesia.

[86]  Andrew Jenkins,et al.  Additive Effects of Sevoflurane and Propofol on &ggr;-Aminobutyric Acid Receptor Function , 2006, Anesthesiology.

[87]  P. Sebel,et al.  Reduction of Isoflurane Minimal Alveolar Concentration by Remifentanil , 1996, Anesthesiology.

[88]  Thomas W. Schnider,et al.  Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development , 1997 .

[89]  Y. Adachi,et al.  Oral clonidine premedication reduces the EC50 of propofol concentration for laryngeal mask airway insertion in male patients , 2002, Acta anaesthesiologica Scandinavica.

[90]  A. McEwan,et al.  MAC reduction of isoflurane by sufentanil. , 1994, British journal of anaesthesia.

[91]  J. Driessen,et al.  Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. , 2010, British journal of anaesthesia.

[92]  Amitai Ziv,et al.  Patient safety and simulation-based medical education , 2000, Medical teacher.

[93]  A. Absalom,et al.  An Overview of TCI & TIVA , 2019 .

[94]  Silke Janitza,et al.  Determination of breath isoprene allows the identification of the expiratory fraction of the propofol breath signal during real-time propofol breath monitoring , 2013, Journal of Clinical Monitoring and Computing.

[95]  David M. Pettigrew,et al.  Performance evaluation of a whole blood propofol analyser , 2011, Journal of Clinical Monitoring and Computing.

[96]  R. Kennedy.  Seeing the future of anesthesia drug dosing: moving the art of anesthesia from impressionism to realism. , 2010, Anesthesia and analgesia.

[97]  C. Mayhew,et al.  Real-time breath monitoring of propofol and its volatile metabolites during surgery using a novel mass spectrometric technique: a feasibility study. , 2003, British journal of anaesthesia.

[98]  E. Eger,et al.  A Comparative Study of Halothane and Halopropane Anesthesia: Including Method for Determining Equipotency , 1963, Anesthesiology.

[99]  S L Shafer,et al.  Response Surface Model for Anesthetic Drug Interactions , 2000, Anesthesiology.

[100]  Steven L Shafer,et al.  Target-controlled Infusions for Intravenous Anesthetics Surfing USA Not ! , 2003 .

[101]  P. White,et al.  A Comparison of Patient State Index and Bispectral Index Values During the Perioperative Period , 2002, Anesthesia and analgesia.

[102]  E. Gepts,et al.  Disposition of Propofol Administered as Constant Rate Intravenous Infusions in Humans , 1987, Anesthesia and analgesia.

[103]  Talmage D Egan,et al.  Opioid–Volatile Anesthetic Synergy: A Response Surface Model with Remifentanil and Sevoflurane as Prototypes , 2006, Anesthesiology.

[104]  Talmage D Egan,et al.  An Evaluation of Remifentanil-Sevoflurane Response Surface Models in Patients Emerging from Anesthesia: Model Improvement Using Effect-Site Sevoflurane Concentrations , 2010, Anesthesia and analgesia.

[105]  Koujirou Yamamoto,et al.  Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain. , 2005, British journal of clinical pharmacology.

[106]  S L Shafer,et al.  Nomenclature for computer-assisted infusion devices. , 1997, Anesthesiology.

[107]  H. Sonntag,et al.  Hepatic and extrahepatic disposition of propofol in patients undergoing coronary bypass surgery. , 1990, British journal of anaesthesia.

[108]  D. Stanski,et al.  Linearity of Pharmacokinetics and Model Estimation of Sufentanil , 1995, Anesthesiology.

[109]  M. Struys,et al.  A Response Surface Model Approach for Continuous Measures of Hypnotic and Analgesic Effect during Sevoflurane–Remifentanil Interaction: Quantifying the Pharmacodynamic Shift Evoked by Stimulation , 2014, Anesthesiology.

[110]  R. Del Río,et al.  Analysis of pharmacodynamic interaction of sevoflurane and propofol on Bispectral Index during general anaesthesia using a response surface model. , 2010, British journal of anaesthesia.

[111]  Hugo Vereecke,et al.  Ability of the Bispectral Index, Autoregressive Modelling with Exogenous Input-derived Auditory Evoked Potentials, and Predicted Propofol Concentrations to Measure Patient Responsiveness during Anesthesia with Propofol and Remifentanil , 2003, Anesthesiology.

[112]  P. Gambús,et al.  Sedation-Analgesia with Propofol and Remifentanil: Concentrations Required to Avoid Gag Reflex in Upper Gastrointestinal Endoscopy , 2015, Anesthesia and analgesia.

[113]  Michel M. R. F. Struys,et al.  A General Purpose Pharmacokinetic Model for Propofol , 2014, Anesthesia and analgesia.

[114]  E. Mortier,et al.  Do we need inhaled anaesthetics to blunt arousal, haemodynamic responses to intubation after i.v. induction with propofol, remifentanil, rocuronium? , 2006, British journal of anaesthesia.

[115]  P. Caminal,et al.  Modeling the Effect of Propofol and Remifentanil Combinations for Sedation-Analgesia in Endoscopic Procedures Using an Adaptive Neuro Fuzzy Inference System (ANFIS) , 2011, Anesthesia and analgesia.

[116]  D R Stanski,et al.  Bayesian Forecasting Improves the Prediction of Intraoperative Plasma Concentrations of Alfentanil , 1988, Anesthesiology.

[117]  E Olofsen,et al.  Propofol Anesthesia and Rational Opioid Selection: Determination of Optimal EC50‐EC95 Propofol‐Opioid Concentrations that Assure Adequate Anesthesia and a Rapid Return of Consciousness , 1997, Anesthesiology.

[118]  Principles of Pharmacokinetic Modeling and Dosimetry , 1997 .

[119]  W. Greco,et al.  The search for synergy: a critical review from a response surface perspective. , 1995, Pharmacological reviews.

[120]  Stephan Schmidt,et al.  Significance of protein binding in pharmacokinetics and pharmacodynamics. , 2010, Journal of pharmaceutical sciences.

[121]  G N Kenny,et al.  Auditory evoked potential index: a quantitative measure of changes in auditory evoked potentials during general anaesthesia , 1997, Anaesthesia.

[122]  M. Struys,et al.  Comparison of computer‐controlled administration of propofol with two manually controlled infusion techniques , 1997, Anaesthesia.

[123]  J. Martyn,et al.  Antiepileptic-Induced Resistance to Neuromuscular Blockers , 2004, Clinical pharmacokinetics.

[124]  J G Bovill,et al.  The Pharmacodynamic Interaction of Propofol and Alfentanil during Lower Abdominal Surgery in Women , 1995, Anesthesiology.

[125]  G. Xie,et al.  A Response Surface Analysis of Propofol–Remifentanil Pharmacodynamic Interaction in Volunteers , 2004, Anesthesiology.

[126]  A. Hoeft,et al.  The Performance of a Target-Controlled Infusion of Propofol in Combination with Remifentanil: A Clinical Investigation with Two Propofol Formulations , 2006, Anesthesia and analgesia.

[127]  E. Bradley,et al.  Midazolam‐Alfentanil Synergism for Anesthetic Induction in Patients , 1989, Anesthesia and analgesia.

[128]  Ronald D. Miller.  Miller's Anesthesia , 2005 .

[129]  H. Derendorf,et al.  When is protein binding important? , 2013, Journal of pharmaceutical sciences.

[130]  P. Janicki,et al.  Propofol inhibits enzymatic degradation of alfentanil and sufentanil by isolated liver microsomes in vitro. , 1992, British journal of anaesthesia.

[131]  T. Bouillon,et al.  Sevoflurane Remifentanil Interaction: Comparison of Different Response Surface Models , 2012, Anesthesiology.

[132]  P. Gambús,et al.  Monitoring hypnotic effect and nociception with two EEG‐derived indices, qCON and qNOX, during general anaesthesia , 2014, Acta anaesthesiologica Scandinavica.

[133]  Steven L. Shafer,et al.  Measuring the predictive performance of computer-controlled infusion pumps , 1992, Journal of Pharmacokinetics and Biopharmaceutics.

[134]  T. Kazama,et al.  Effect of remifentanil on plasma propofol concentration and bispectral index during propofol anaesthesia. , 2011, British journal of anaesthesia.

[135]  A. Wood,et al.  Effect of i.v. anaesthesia with propofol on drug distribution and metabolism in the dog. , 1991, British Journal of Anaesthesia.

[136]  Cris D. LaPierre,et al.  Response Surface Model Predictions of Wake-Up Time During Scoliosis Surgery: Reprint , 2014, Anesthesia and analgesia.

[137]  Erik Olofsen,et al.  Propofol Reduces Perioperative Remifentanil Requirements in a Synergistic Manner: Response Surface Modeling of Perioperative Remifentanil–Propofol Interactions , 2003, Anesthesiology.